About Beta-3 adrenergic receptor
Beta-3 adrenergic receptor (ADRB3) is a protein
from Homo sapiens identified by UniProt accession
P13945, 408 residues long.
MolForge cross-references it against 0 known binders and
367 disease associations.
Target properties
| Protein name | Beta-3 adrenergic receptor |
| UniProt accession | P13945 |
| Gene | ADRB3 |
| Organism | Homo sapiens |
| Length | 408 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (16)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (367)
Diseases linked to this target (Open Targets).
- myocardial infarction · score 0.62
- overactive bladder · score 0.62
- hypertension · score 0.61
- pain · score 0.60
- hypotension · score 0.60
- asthma · score 0.60
- Sepsis · score 0.60
- heart failure · score 0.59
- congestive heart failure · score 0.59
- sudden cardiac arrest · score 0.59
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P13945-F1 | alphafold | PREDICTED | 78.93 | — |
Amino-acid sequence (408 residues)
MAPWPHENSS LAPWPDLPTL APNTANTSGL PGVPWEAALA GALLALAVLA TVGGNLLVIV AIAWTPRLQT MTNVFVTSLA AADLVMGLLV VPPAATLALT GHWPLGATGC ELWTSVDVLC VTASIETLCA LAVDRYLAVT NPLRYGALVT KRCARTAVVL VWVVSAAVSF APIMSQWWRV GADAEAQRCH SNPRCCAFAS NMPYVLLSSS VSFYLPLLVM LFVYARVFVV ATRQLRLLRG ELGRFPPEES PPAPSRSLAP APVGTCAPPE GVPACGRRPA RLLPLREHRA LCTLGLIMGT FTLCWLPFFL ANVLRALGGP SLVPGPAFLA LNWLGYANSA FNPLIYCRSP DFRSAFRRLL CRCGRRLPPE PCAAARPALF PSGVPAARSS PAQPRLCQRL DGASWGVS
Explore Beta-3 adrenergic receptor with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets